| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.991 | 0.002 | 0.991 | Vasodilator, coronary | 0.989 0.002 DBMET00012 | ||
| 0.894 | 0.004 | 0.894 | Cardiotonic | 0.864 0.004 DBMET00012 | ||
| 0.88 | 0.003 | 0.88 | Spasmolytic | 0.774 0.004 DBMET00012 | ||
| 0.803 | 0.005 | 0.803 | Thyroid hormone antagonist | 0.748 0.007 DBMET00012 | ||
| 0.712 | 0.009 | 0.712 | Thyroid hormone beta antagonist | 0.664 0.013 DBMET00012 | ||
| 0.566 | 0.008 | 0.566 | Vasodilator | 0.55 0.009 DBMET00012 | ||
| 0.473 | 0.037 | 0.473 | Aldehyde oxidase inhibitor | |||
| 0.435 | 0.004 | 0.435 | Alpha 2b adrenoreceptor antagonist | 0.415 0.005 DBMET00012 | ||
| 0.417 | 0.004 | 0.417 | Uric acid excretion stimulant | 0.392 0.004 DBMET00012 | ||
| 0.404 | 0.016 | 0.413 | Sodium/bile acid cotransporter inhibitor | 0.413 0.014 DBMET00012 | DBMET00012 | |
| 0.379 | 0.002 | 0.379 | Thyroid hormone alpha antagonist | 0.293 0.002 DBMET00012 | ||
| 0.413 | 0.061 | 0.413 | Transcription factor NF kappa B inhibitor | 0.341 0.08 DBMET00012 | ||
| 0.362 | 0.011 | 0.362 | Protein-tyrosine phosphatase inhibitor | 0.34 0.013 DBMET00012 | ||
| 0.374 | 0.032 | 0.374 | HERG channel blocker | 0.23 0.074 DBMET00012 | ||
| 0.324 | 0.004 | 0.324 | CYP2A6 inhibitor | 0.286 0.004 DBMET00012 | ||
| 0.328 | 0.009 | 0.328 | Protein-tyrosine phosphatase 1B inhibitor | 0.299 0.011 DBMET00012 | ||
| 0.341 | 0.035 | 0.341 | Potassium channel blocker | 0.218 0.082 DBMET00012 | ||
| 0.331 | 0.041 | 0.331 | Potassium channel (Voltage-sensitive) blocker | 0.215 0.085 DBMET00012 | ||
| 0.28 | 0.004 | 0.28 | Acetylcholine M4 receptor antagonist | 0.137 0.013 DBMET00012 | ||
| 0.302 | 0.029 | 0.302 | P-glycoprotein inhibitor | 0.257 0.039 DBMET00012 | ||
| 0.334 | 0.061 | 0.334 | Calcium channel activator | 0.293 0.099 DBMET00012 | ||
| 0.303 | 0.032 | 0.303 | Tyrosine 3 hydroxylase inhibitor | 0.243 0.075 DBMET00012 | ||
| 0.279 | 0.049 | 0.279 | Amyloid beta aggregation inhibitor | 0.236 0.062 DBMET00012 | ||
| 0.241 | 0.02 | 0.241 | 5 Hydroxytryptamine 2B antagonist | 0.147 0.042 DBMET00012 | ||
| 0.24 | 0.022 | 0.24 | Anesthetic local | 0.162 0.044 DBMET00012 | ||
| 0.297 | 0.093 | 0.309 | Cholesterol antagonist | 0.309 0.086 DBMET00012 | DBMET00012 | |
| 0.266 | 0.062 | 0.266 | Free radical scavenger | 0.25 0.069 DBMET00012 | ||
| 0.336 | 0.148 | 0.336 | Apoptosis agonist | 0.326 0.155 DBMET00012 | ||
| 0.222 | 0.034 | 0.222 | Acetylcholine M1 receptor antagonist | 0.163 0.064 DBMET00012 | ||
| 0.267 | 0.086 | 0.267 | Hypoxia-inducible factor 1 alpha inhibitor | 0.194 0.159 DBMET00012 | ||
| 0.202 | 0.036 | 0.202 | Tubulin antagonist | 0.2 0.037 DBMET00012 | ||
| 0.273 | 0.108 | 0.273 | Antithrombotic | 0.195 0.184 DBMET00012 | ||
| 0.167 | 0.005 | 0.227 | Beta adrenoreceptor antagonist | 0.227 0.004 DBMET00012 | DBMET00012 | |
| 0.202 | 0.051 | 0.219 | Thrombolytic | 0.219 0.043 DBMET00012 | DBMET00012 | |
| 0.164 | 0.013 | 0.164 | Dopamine D1 antagonist | 0.092 0.028 DBMET00012 | ||
| 0.154 | 0.01 | 0.154 | Purinergic P2X2 antagonist | 0.151 0.011 DBMET00012 | ||
| 0.183 | 0.04 | 0.183 | Hemostatic | 0.123 0.108 DBMET00012 | ||
| 0.301 | 0.164 | 0.301 | 5 Hydroxytryptamine release inhibitor | |||
| 0.154 | 0.018 | 0.154 | Electron transport complex I inhibitor | 0.148 0.022 DBMET00012 | ||
| 0.144 | 0.008 | 0.144 | Acetylcholine M5 receptor antagonist | 0.123 0.012 DBMET00012 | ||
| 0.195 | 0.06 | 0.195 | Lipocortins synthesis antagonist | |||
| 0.139 | 0.005 | 0.139 | Plasminogen activator inhibitor antagonist | 0.135 0.005 DBMET00012 | ||
| 0.155 | 0.023 | 0.155 | Multidrug resistance-associated protein 1 inhibitor | 0.13 0.038 DBMET00012 | ||
| 0.138 | 0.014 | 0.182 | Adenosine A3 receptor antagonist | 0.182 0.01 DBMET00012 | DBMET00012 | |
| 0.148 | 0.027 | 0.148 | 5 Hydroxytryptamine 2C antagonist | 0.112 0.039 DBMET00012 | ||
| 0.288 | 0.168 | 0.332 | Calcium channel L-type activator | 0.332 0.131 DBMET00012 | DBMET00012 | |
| 0.132 | 0.013 | 0.132 | Calcium channel L-type blocker | 0.099 0.025 DBMET00012 | ||
| 0.16 | 0.042 | 0.16 | Aldehyde dehydrogenase inhibitor | |||
| 0.195 | 0.078 | 0.195 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.171 0.105 DBMET00012 | ||
| 0.139 | 0.025 | 0.139 | Alpha 2a adrenoreceptor antagonist | 0.12 0.029 DBMET00012 | ||
| 0.215 | 0.104 | 0.215 | Antioxidant | 0.195 0.117 DBMET00012 | ||
| 0.129 | 0.018 | 0.129 | Dopamine D3 antagonist | 0.114 0.021 DBMET00012 | ||
| 0.125 | 0.015 | 0.125 | Acetylcholine M2 receptor antagonist | 0.078 0.03 DBMET00012 | ||
| 0.119 | 0.01 | 0.14 | Beta 3 adrenoreceptor antagonist | 0.14 0.007 DBMET00012 | DBMET00012 | |
| 0.126 | 0.018 | 0.132 | Histamine H2 receptor antagonist | 0.132 0.015 DBMET00012 | DBMET00012 | |
| 0.148 | 0.045 | 0.148 | 5 Hydroxytryptamine 2 antagonist | 0.113 0.064 DBMET00012 | ||
| 0.188 | 0.091 | 0.188 | Antimitotic | 0.171 0.102 DBMET00012 | ||
| 0.134 | 0.043 | 0.147 | Photosensitizer | 0.147 0.033 DBMET00012 | DBMET00012 | |
| 0.15 | 0.059 | 0.15 | Calcium channel blocker | 0.132 0.075 DBMET00012 | ||
| 0.129 | 0.039 | 0.129 | Estrogen antagonist | 0.115 0.064 DBMET00012 | ||
| 0.202 | 0.112 | 0.253 | Calpain inhibitor | 0.253 0.062 DBMET00012 | DBMET00012 | |
| 0.114 | 0.024 | 0.114 | ATPase (Vacuolar H+) inhibitor | 0.107 0.031 DBMET00012 | ||
| 0.128 | 0.042 | 0.22 | Antiadrenergic | 0.22 0.021 DBMET00012 | DBMET00012 | |
| 0.178 | 0.094 | 0.178 | Psychostimulant | 0.164 0.104 DBMET00012 | ||
| 0.163 | 0.08 | 0.163 | ATPase inhibitor | |||
| 0.198 | 0.117 | 0.212 | DNA damaging | 0.212 0.106 DBMET00012 | DBMET00012 | |
| 0.181 | 0.104 | 0.22 | 5 Hydroxytryptamine 3E antagonist | 0.22 0.037 DBMET00012 | DBMET00012 | |
| 0.115 | 0.038 | 0.115 | Alpha 2 adrenoreceptor antagonist | 0.107 0.043 DBMET00012 | ||
| 0.181 | 0.11 | 0.181 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.089 | 0.022 | 0.089 | Dopamine uptake inhibitor | 0.07 0.03 DBMET00012 | ||
| 0.135 | 0.072 | 0.135 | Bone formation stimulant | 0.125 0.081 DBMET00012 | ||
| 0.07 | 0.008 | 0.07 | Sigma 1 receptor antagonist | 0.031 0.017 DBMET00012 | ||
| 0.094 | 0.034 | 0.094 | Interferon agonist | |||
| 0.108 | 0.049 | 0.204 | Adrenaline antagonist | 0.204 0.023 DBMET00012 | DBMET00012 | |
| 0.116 | 0.058 | 0.116 | Chelator | 0.096 0.084 DBMET00012 | ||
| 0.085 | 0.027 | 0.085 | Peroxisome proliferator-activated receptor gamma antagonist | 0.083 0.03 DBMET00012 | ||
| 0.092 | 0.04 | 0.095 | Somatostatin 1 agonist | 0.095 0.037 DBMET00012 | DBMET00012 | |
| 0.151 | 0.1 | 0.151 | Amyloid beta precursor protein antagonist | 0.151 0.1 DBMET00012 | ||
| 0.131 | 0.08 | 0.131 | Farnesoid X receptor antagonist | 0.128 0.085 DBMET00012 | ||
| 0.073 | 0.023 | 0.11 | Beta 1 adrenoreceptor antagonist | 0.11 0.008 DBMET00012 | DBMET00012 | |
| 0.071 | 0.023 | 0.071 | Sigma receptor antagonist | 0.041 0.04 DBMET00012 | ||
| 0.086 | 0.04 | 0.086 | Estrogen receptor alpha antagonist | |||
| 0.098 | 0.053 | 0.098 | ABCA1 expression enhancer | 0.089 0.067 DBMET00012 | ||
| 0.094 | 0.05 | 0.094 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.095 | 0.051 | 0.101 | Aminoacyl-tRNA synthetase inhibitor | 0.101 0.044 DBMET00012 | DBMET00012 | |
| 0.094 | 0.051 | 0.094 | Histamine N-methyltransferase inhibitor | |||
| 0.082 | 0.039 | 0.082 | Dopamine D2 antagonist | 0.075 0.041 DBMET00012 | ||
| 0.114 | 0.073 | 0.114 | Acetylcholine muscarinic antagonist | |||
| 0.102 | 0.061 | 0.102 | Estrogen receptor beta antagonist | |||
| 0.083 | 0.046 | 0.083 | Dopamine antagonist | 0.074 0.051 DBMET00012 | ||
| 0.079 | 0.042 | 0.079 | Peroxisome proliferator-activated receptor gamma agonist | 0.075 0.045 DBMET00012 | ||
| 0.049 | 0.012 | 0.049 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.062 | 0.027 | 0.064 | Thromboxane A2 antagonist | 0.064 0.025 DBMET00012 | DBMET00012 | |
| 0.035 | 0.004 | 0.035 | Thyroid hormone alpha agonist | 0.033 0.004 DBMET00012 | ||
| 0.131 | 0.101 | 0.131 | Sigma receptor agonist | |||
| 0.094 | 0.066 | 0.094 | Xanthine oxidase inhibitor | |||
| 0.089 | 0.065 | 0.089 | Antihistaminic | |||
| 0.109 | 0.085 | 0.109 | Cholinergic antagonist | |||
| 0.058 | 0.034 | 0.066 | Thromboxane antagonist | 0.066 0.028 DBMET00012 | DBMET00012 | |
| 0.054 | 0.031 | 0.092 | Beta 2 adrenoreceptor antagonist | 0.092 0.009 DBMET00012 | DBMET00012 | |
| 0.196 | 0.174 | 0.196 | Angiogenesis inhibitor | 0.196 0.174 DBMET00012 | ||
| 0.043 | 0.021 | 0.043 | Retinoid X receptor agonist | |||
| 0.036 | 0.017 | 0.036 | Calcium-independent phospholipase A2 inhibitor | 0.036 0.017 DBMET00012 | ||
| 0.09 | 0.072 | 0.09 | Sphingomyelinase inhibitor | |||
| 0.104 | 0.087 | 0.104 | Acetylcholine antagonist | |||
| 0.104 | 0.087 | 0.104 | MAO inhibitor | |||
| 0.058 | 0.043 | 0.058 | Acetylcholine M3 receptor antagonist | |||
| 0.038 | 0.025 | 0.038 | Delayed rectifier potassium channel blocker | |||
| 0.062 | 0.049 | 0.062 | Interferon inducer | |||
| 0.028 | 0.015 | 0.028 | Thyroid hormone agonist | 0.024 0.022 DBMET00012 | ||
| 0.078 | 0.066 | 0.078 | Histamine antagonist | |||
| 0.033 | 0.025 | 0.05 | Melatonin receptor 1A agonist | 0.05 0.008 DBMET00012 | DBMET00012 | |
| 0.026 | 0.018 | 0.026 | Complement factor 1r inhibitor | 0.026 0.018 DBMET00012 | ||
| 0.094 | 0.088 | 0.094 | DOPA decarboxylase inhibitor | |||
| 0.047 | 0.041 | 0.047 | Squalene epoxidase inhibitor | |||
| 0.025 | 0.024 | 0.037 | Melatonin antagonist | 0.037 0.011 DBMET00012 | DBMET00012 | |
| 0.016 | 0.017 | 0.025 | Melatonin 1 antagonist | 0.025 0.008 DBMET00012 | DBMET00012 | |
| 0.075 | 0.076 | 0.09 | Alpha adrenoreceptor antagonist | 0.09 0.063 DBMET00012 | DBMET00012 | |
| 0.012 | 0.013 | 0.034 | Melatonin receptor 1A antagonist | 0.034 0.004 DBMET00012 | DBMET00012 | |
| 0.035 | 0.039 | 0.037 | Growth hormone release inhibitor | 0.037 0.036 DBMET00012 | DBMET00012 | |
| 0.048 | 0.054 | 0.051 | Thromboxane synthase inhibitor | 0.051 0.045 DBMET00012 | DBMET00012 | |
| 0.045 | 0.054 | 0.055 | Dopamine D4 antagonist | 0.055 0.045 DBMET00012 | DBMET00012 | |
| 0.056 | 0.071 | 0.063 | Beta 2 adrenoreceptor agonist | 0.063 0.037 DBMET00012 | DBMET00012 | |
| 0.024 | 0.04 | 0.038 | Melatonin 2 agonist | 0.038 0.018 DBMET00012 | DBMET00012 | |
| 0.02 | 0.039 | 0.027 | Acid ceramidase inhibitor | 0.027 0.014 DBMET00012 | DBMET00012 | |
| 0.222 | 0.245 | 0.288 | Cyclophilin D inhibitor | 0.288 0.174 DBMET00012 | DBMET00012 | |
| 0.04 | 0.062 | 0.048 | Beta adrenoreceptor agonist | 0.048 0.022 DBMET00012 | DBMET00012 | |
| 0.114 | 0.147 | 0.15 | Angiogenesis stimulant | 0.15 0.122 DBMET00012 | DBMET00012 | |
| 0.041 | 0.077 | 0.049 | Vanilloid 2 antagonist | 0.049 0.043 DBMET00012 | DBMET00012 | |
| 0.059 | 0.096 | 0.113 | Adrenaline agonist | 0.113 0.029 DBMET00012 | DBMET00012 | |
| 0.02 | 0.057 | 0.033 | Melatonin agonist | 0.033 0.022 DBMET00012 | DBMET00012 | |
| 0.012 | 0.06 | 0.024 | Beta 1 adrenoreceptor agonist | 0.024 0.014 DBMET00012 | DBMET00012 | |
| 0.131 | 0.223 | 0.251 | 5 Hydroxytryptamine release stimulant | 0.251 0.088 DBMET00012 | DBMET00012 | |
| 0.146 | 0.247 | 0.262 | Calpain 2 inhibitor | 0.262 0.141 DBMET00012 | DBMET00012 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |